A Microneurography Study of NaV1.8 Inhibition in Healthy Adults
Clinical trial NCT06420765 · COMPLETED
Trial details
- NCT number
- NCT06420765
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-21
- Primary completion
- 2025-03-22
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.